Safety and efficacy of EIK1003, a selective PARP1 inhibitor, as monotherapy in participants with advanced solid tumors.

Authors: Guru P. Sonpavde, Drew W. Rasco, Jian Zhang, Yongsheng Li, Jianqing Zhu, Joohyuk Sohn, Christina Teng, Bernard Doger, Chih-Yi Hsieh, Yayan Zhang, Yawei Zhang, Viola Chen, Gerald Steven Falchook

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.3122

Source: Full article

---

Abstract

3122